EarlyDiagnostics: Gregory Critchfield

EarlyDiagnostics has appointed Gregory Critchfield as its co-CEO, effective Jan. 1. Critchfield was a board member, former chairman, and CEO of Sera Prognostics, leading it from its very early financing stages in 2010 through its successful IPO in 2021. Before Sera, he served as president of Myriad Genetic Laboratories. He also had a stint as chief medical and science officer for Quest Diagnostics, overseeing medical and innovation activities in its transition from Corning Clinical Laboratories. Critchfield has served on the faculty of three medical schools: University of Minnesota, Wayne State University, and Duke University, and as a practicing clinical pathologist with Intermountain Healthcare.